查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1831711

分子诊断市场，规模，占有率，趋势，产业分析报告:各产品，检验场所，各技术，各用途，各地区，2025年～2034年的市场预测

Molecular Diagnostics Market Size, Share, Trend, Industry Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology, By Application, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 127 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，分子诊断市场规模将达到 380.1 亿美元。本研究报告深入分析了当前的市场动态，并对未来的市场成长进行了展望。

分子诊断市场专注于利用分子生物学技术检测患者样本中的遗传物质、蛋白质和其他特定生物标记物，从而实现疾病的精准诊断、预后和监测。推动此市场发展的因素包括：对精准、快速、微创诊断方法的需求不断增长，以支持个人化医疗；传染病、癌症和遗传性疾病的日益流行，也加速了分子诊断技术在临床应用中的普及。

数位PCR、新一代定序和微阵列等技术的持续进步正在提高检测的灵敏度、特异性和周转时间，从而增强临床决策能力。

医护人员和病患对疾病早期检测的认识不断提高，推动了其在预防保健中的广泛应用。人工智慧和自动化技术在检测平台中的整合正在简化工作流程、减少错误并提高实验室效率。即时分子检测（POC​​）的普及使诊断更加便捷及时，尤其是在急诊环境中。诊断公司加大研发投入，催生出具有更广泛检测项目的创新检测方法与平台。行业趋势包括向分散式检测模式的转变、标靶治疗伴随诊断的成长以及诊断开发商和製药公司之间合作的加强。机会包括扩展检测组合以应对新出现的病原体、透过与数位医疗的整合利用远端诊断以及推进多重检测以在单次检测中检测多种病理。随着精准医疗不断重塑医疗保健格局，对快速、准确且可扩展的诊断解决方案的需求日益增长，该市场有望实现持续成长。

分子诊断市场报告亮点

按产品划分，试剂系统细分市场将占主导地位，约占收入占有率的 66%，这主要得益于常规分子诊断工作流程中耗材的持续需求。

按检测地点划分，中心实验室细分市场将在 2024 年占 80% 的收入占有率，这主要归功于处理大量检测所需的先进设备和专业知识。

北美分子诊断市场将占最大的收入占有率，达 41%，这得益于先进分子检测技术的广泛应用和完善的医疗保健基础设施。

亚太市场预计将在 2025 年至 2034 年间实现显着增长，这主要得益于医疗保健投资的增加、先进诊断平台的快速普及以及慢性病和传染病负担的日益加重。

全球主要公司包括：雅培、安捷伦科技公司、BD、生物梅里埃、Bio-Rad Laboratories, Inc.、丹纳赫、罗氏、基立福、豪洛捷（Gen Probe）、Illumina, Inc.、凯杰、西门子医疗和希森美康公司。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 分子诊断市场洞察

  • 市场概述
  • 分子诊断市场动态
    • 促进因素和机会
      • 常见传染病
      • 支持性监管和资金举措
    • 限制因素和挑战
      • 设备和试剂成本高昂限制了其应用
  • PESTEL 分析
  • 分子诊断市场力量评估趋势
  • 价值链分析

第5章 分子诊断市场:各产品

  • 主要调查结果
  • 简介
  • 设备
  • 试剂
  • 其他

第6章 分子诊断市场:检验场所

  • 主要调查结果
  • 简介
  • 照护现场
  • 自我检测或OTC
  • 中心实验室

第7章 分子诊断市场:各技术

  • 主要调查结果
  • 简介
  • 聚合酵素链锁反应(PCR)
  • 恆温核酸增幅技术(INAAT)
  • 晶片和微阵列
  • 质谱分析
  • 转录介导扩增(TMA)
  • 其他

第8章 分子诊断市场:各用途

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 药理基因学
  • 感染疾病
  • 遗传基因检验
  • 神经疾病
  • 心血管疾病
  • 微生物学
  • 其他

第9章 分子诊断市场:各地区

  • 主要调查结果
  • 简介
    • 分子诊断市场评估:地区，2020-2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各检验场所，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各技术，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各检验场所，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各技术，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各检验场所，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:各技术，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各检验场所，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各技术，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:各检验场所，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各技术，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Abbott
  • Agilent Technologies, Inc.
  • BD
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche, Ltd
  • Grifols
  • Hologic Inc.(Gen Probe)
  • Illumina, Inc.
  • QIAGEN
  • Siemens Healthineers AG
  • Sysmex Corporation
Product Code: PM6073

The molecular diagnostics market size is expected to reach USD 38.01 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology, By Application, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The molecular diagnostics market focuses on the use of molecular biology techniques to detect genetic material, proteins, or other specific biomarkers in a patient's sample, enabling precise diagnosis, prognosis, and monitoring of diseases. This market has grown significantly due to the increasing demand for accurate, rapid, and minimally invasive diagnostic methods that support personalized medicine. The rising prevalence of infectious diseases, cancer, and genetic disorders has accelerated the adoption of molecular diagnostics in clinical settings. Continuous advancements in technologies such as digital PCR, next-generation sequencing, and microarrays are improving test sensitivity, specificity, and turnaround times, enhancing clinical decision-making.

Growing awareness among healthcare providers and patients about early disease detection is driving wider usage in preventive care. The integration of AI and automation in testing platforms is streamlining workflows and reducing errors, improving efficiency in laboratories. Expansion of point-of-care molecular testing is making diagnostics more accessible and timely, particularly in urgent care situations. Increasing investments in research and development by diagnostic companies is leading to innovative assays and platforms with broader test menus. Industry trends include a shift toward decentralized testing models, growth in companion diagnostics for targeted therapies, and rising collaborations between diagnostic developers and pharmaceutical companies. Opportunities lie in expanding test portfolios to address emerging pathogens, leveraging digital health integration for remote diagnostics, and advancing multiplex testing to detect multiple conditions in a single run. The market is positioned for sustained growth as precision medicine continues to shape healthcare, demanding fast, accurate, and scalable diagnostic solutions.

Molecular Diagnostics Market Report Highlights

By product, the reagents systems segment dominated the market with ~66% of the revenue share due to continuous demand for consumables in routine molecular diagnostic workflows.

Based on test location, the central laboratories segment held ~80% of the revenue share in 2024 due to their capability to process high testing volumes with advanced instrumentation and specialized expertise.

The North America molecular diagnostics market accounted for the largest revenue share of ~41% due to strong adoption of advanced molecular testing technologies, and supported by a well-established healthcare infrastructure.

The Asia Pacific market is expected to grow significantly during 2025-2034 due to increasing healthcare investments, rapid adoption of advanced diagnostic platforms, and the rising burden of chronic and infectious diseases.

A few global key players include Abbott; Agilent Technologies, Inc.; BD; BIOMERIEUX; Bio-Rad Laboratories, Inc.; Danaher; F. Hoffmann-La Roche, Ltd.; Grifols; Hologic Inc. (Gen Probe); Illumina, Inc.; QIAGEN; Siemens Healthineers AG; and Sysmex Corporation.

Polaris Market Research has segmented the molecular diagnostics market report on the basis of product, test location, technology, application, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Instruments

Reagents

Others

By Test Location Outlook (Revenue, USD Billion, 2020-2034)

Point of Care

Self-test or OTC

Central Laboratories

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Polymerase Chain Reaction (PCR)

PCR, by Procedure

Nucleic Acid Extraction

Others

PCR, by Type

Multiplex PCR

Other PCR

PCR, by Product

Instruments

Reagents

Others

In Situ Hybridization (ISH)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Chips and Microarrays

Mass Spectrometry

Transcription Mediated Amplification (TMA)

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Pharmacogenomics

Infectious Disease

MRSA

Clostridium Difficile

Tuberculosis and Drug-Resistant TB

Meningitis

Gonorrhea

HIV

Hepatitis C

Hepatitis B

Others

Genetic Testing

Neurological Disease

Cardiovascular Disease

Microbiology

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Molecular Diagnostics Market Insights

  • 4.1. Molecular Diagnostics Market - Market Snapshot
  • 4.2. Molecular Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Infectious Diseases
      • 4.2.1.2. Supportive Regulatory and Funding Initiatives
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of instruments and reagents limits adoption
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Diagnostics Market Power Rating Trends
  • 4.6. Value Chain Analysis

5. Molecular Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Instruments
    • 5.3.1. Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 5.4. Reagents
    • 5.4.1. Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
  • 5.5. Others
    • 5.5.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Molecular Diagnostics Market, by Test Location

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • 6.3. Point of care
    • 6.3.1. Molecular Diagnostics Market, by Point of care, by Region, 2020-2034 (USD Billion)
  • 6.4. Self-test or OTC
    • 6.4.1. Molecular Diagnostics Market, by Self-test or OTC, by Region, 2020-2034 (USD Billion)
  • 6.5. Central laboratories
    • 6.5.1. Molecular Diagnostics Market, by Central laboratories, by Region, 2020-2034 (USD Billion)

7. Molecular Diagnostics Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Polymerase chain reaction (PCR)
    • 7.3.1. Molecular Diagnostics Market, by Polymerase chain reaction (PCR), by Region, 2020-2034 (USD Billion)
    • 7.3.2. PCR, by Procedure
      • 7.3.2.1. Molecular Diagnostics Market, by PCR, by Procedure, by Region, 2020-2034 (USD Billion)
      • 7.3.2.2. Nucleic Acid Extraction
      • 7.3.2.2.1. Molecular Diagnostics Market, by Nucleic Acid Extraction, by Region, 2020-2034 (USD Billion)
      • 7.3.2.3. Others
      • 7.3.2.3.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
    • 7.3.3. PCR, by Type
      • 7.3.3.1. Molecular Diagnostics Market, by PCR, by Type, by Region, 2020-2034 (USD Billion)
      • 7.3.3.2. Multiplex PCR
      • 7.3.3.2.1. Molecular Diagnostics Market, by Multiplex PCR, by Region, 2020-2034 (USD Billion)
      • 7.3.3.3. Other PCR
      • 7.3.3.3.1. Molecular Diagnostics Market, by Other PCR, by Region, 2020-2034 (USD Billion)
    • 7.3.4. PCR, by Product
      • 7.3.4.1. Molecular Diagnostics Market, by PCR, by Product, by Region, 2020-2034 (USD Billion)
      • 7.3.4.2. Instruments
      • 7.3.4.2.1. Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
      • 7.3.4.3. Reagents
      • 7.3.4.3.1. Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
      • 7.3.4.4. Others
      • 7.3.4.4.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
    • 7.3.5. In Situ Hybridization (ISH)
      • 7.3.5.1. Molecular Diagnostics Market, by In Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
  • 7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.4.1. Molecular Diagnostics Market, by Isothermal Nucleic Acid Amplification Technology (INAAT), by Region, 2020-2034 (USD Billion)
  • 7.5. Chips and Microarrays
    • 7.5.1. Molecular Diagnostics Market, by Chips and Microarrays, by Region, 2020-2034 (USD Billion)
  • 7.6. Mass Spectrometry
    • 7.6.1. Molecular Diagnostics Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
  • 7.7. Transcription Mediated Amplification (TMA)
    • 7.7.1. Molecular Diagnostics Market, by Transcription Mediated Amplification (TMA), by Region, 2020-2034 (USD Billion)
  • 7.8. Others
    • 7.8.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Molecular Diagnostics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Oncology
    • 8.3.1. Molecular Diagnostics Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 8.4. Pharmacogenomics
    • 8.4.1. Molecular Diagnostics Market, by Pharmacogenomics, by Region, 2020-2034 (USD Billion)
  • 8.5. Infectious disease
    • 8.5.1. Molecular Diagnostics Market, by Infectious disease, by Region, 2020-2034 (USD Billion)
    • 8.5.2. Oncology
      • 8.5.2.1. Molecular Diagnostics Market, by Oncology, by Region, 2020-2034 (USD Billion)
    • 8.5.3. MRSA
      • 8.5.3.1. Molecular Diagnostics Market, by MRSA, by Region, 2020-2034 (USD Billion)
    • 8.5.4. Clostridium difficile
      • 8.5.4.1. Molecular Diagnostics Market, by Clostridium difficile, by Region, 2020-2034 (USD Billion)
    • 8.5.5. Tuberculosis and drug-resistant TB
      • 8.5.5.1. Molecular Diagnostics Market, by Tuberculosis and drug-resistant TB, by Region, 2020-2034 (USD Billion)
    • 8.5.6. Meningitis
      • 8.5.6.1. Molecular Diagnostics Market, by Meningitis, by Region, 2020-2034 (USD Billion)
    • 8.5.7. Gonorrhea
      • 8.5.7.1. Molecular Diagnostics Market, by Gonorrhea, by Region, 2020-2034 (USD Billion)
    • 8.5.8. HIV
      • 8.5.8.1. Molecular Diagnostics Market, by HIV, by Region, 2020-2034 (USD Billion)
    • 8.5.9. Hepatitis C
      • 8.5.9.1. Molecular Diagnostics Market, by Hepatitis C, by Region, 2020-2034 (USD Billion)
    • 8.5.10. Hepatitis B
      • 8.5.10.1. Molecular Diagnostics Market, by Hepatitis B, by Region, 2020-2034 (USD Billion)
    • 8.5.11. Others
      • 8.5.11.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 8.6. Genetic testing
    • 8.6.1. Molecular Diagnostics Market, by Genetic testing, by Region, 2020-2034 (USD Billion)
  • 8.7. Neurological disease
    • 8.7.1. Molecular Diagnostics Market, by Neurological disease, by Region, 2020-2034 (USD Billion)
  • 8.8. Cardiovascular disease
    • 8.8.1. Molecular Diagnostics Market, by Cardiovascular disease, by Region, 2020-2034 (USD Billion)
  • 8.9. Microbiology
    • 8.9.1. Molecular Diagnostics Market, by Microbiology, by Region, 2020-2034 (USD Billion)
  • 8.10. Others
    • 8.10.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Molecular Diagnostics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Molecular Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Molecular Diagnostics Market - North America
    • 9.3.1. North America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.3.3. North America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.5. Molecular Diagnostics Market - US
      • 9.3.5.1. US: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.6. Molecular Diagnostics Market - Canada
      • 9.3.6.1. Canada: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.4. Molecular Diagnostics Market - Europe
    • 9.4.1. Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.5. Molecular Diagnostics Market - UK
      • 9.4.5.1. UK: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.6. Molecular Diagnostics Market - France
      • 9.4.6.1. France: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.7. Molecular Diagnostics Market - Germany
      • 9.4.7.1. Germany: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.8. Molecular Diagnostics Market - Italy
      • 9.4.8.1. Italy: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.9. Molecular Diagnostics Market - Spain
      • 9.4.9.1. Spain: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.10. Molecular Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.11. Molecular Diagnostics Market - Russia
      • 9.4.11.1. Russia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.12. Molecular Diagnostics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.5. Molecular Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.5. Molecular Diagnostics Market - China
      • 9.5.5.1. China: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.6. Molecular Diagnostics Market - India
      • 9.5.6.1. India: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.7. Molecular Diagnostics Market - Malaysia
      • 9.5.7.1. Malaysia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.8. Molecular Diagnostics Market - Japan
      • 9.5.8.1. Japan: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.9. Molecular Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.10. Molecular Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.11. Molecular Diagnostics Market - Australia
      • 9.5.11.1. Australia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.12. Molecular Diagnostics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.6. Molecular Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.5. Molecular Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.6. Molecular Diagnostics Market - UAE
      • 9.6.6.1. UAE: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.7. Molecular Diagnostics Market - Israel
      • 9.6.7.1. Israel: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.8. Molecular Diagnostics Market - South Africa
      • 9.6.8.1. South Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.9. Molecular Diagnostics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.7. Molecular Diagnostics Market - Latin America
    • 9.7.1. Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.5. Molecular Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.6. Molecular Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.7. Molecular Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.8. Molecular Diagnostics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BD
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BIOMERIEUX
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Bio-Rad Laboratories, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Danaher
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. F. Hoffmann-La Roche, Ltd
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Grifols
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Hologic Inc. (Gen Probe)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Illumina, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. QIAGEN
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Siemens Healthineers AG
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Sysmex Corporation
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development

List of Tables:

  • Table 1 Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 2 Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 3 Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 4 Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 5 North America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 6 North America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 7 North America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 8 North America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 US: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 10 US: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 11 US: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 12 US: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 13 Canada: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 15 Canada: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 17 Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 19 Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 21 UK: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 22 UK: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 23 UK: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 24 UK: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 25 France: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 26 France: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 27 France: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 28 France: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 29 Germany: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 31 Germany: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 32 Germany: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 33 Italy: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 35 Italy: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Italy: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 37 Spain: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 39 Spain: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Spain: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 45 Russia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 47 Russia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Russia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 57 China: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 58 China: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 59 China: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 60 China: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 61 India: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 62 India: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 63 India: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 64 India: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 Japan: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 71 Japan: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Japan: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 77 South Korea: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 79 South Korea: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 80 South Korea: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 81 Australia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 83 Australia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Australia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 97 UAE: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 99 UAE: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 100 UAE: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 101 Israel: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 103 Israel: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 104 Israel: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 105 South Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 107 South Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 108 South Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 113 Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 115 Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 117 Mexico: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 119 Mexico: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Mexico: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 121 Brazil: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 123 Brazil: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 124 Brazil: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 125 Argentina: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 127 Argentina: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 128 Argentina: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Molecular Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Molecular Diagnostics Market, By Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Test Location
  • Figure 9. Molecular Diagnostics Market, By Test Location, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Molecular Diagnostics Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Technology
  • Figure 13. Molecular Diagnostics Market, by Technology, 2024 & 2034 (USD Billion)